Effects of Age on the Detection and Management of Breast Cancer A McGuire, JAL Brown, C Malone, R McLaughlin, MJ Kerin Cancers 7 (2), 908-929, 2015 | 384 | 2015 |
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. A McGuire, JA Brown, MJ Kerin Cancer Metastasis Rev. 34, 145–155, 2015 | 348 | 2015 |
Rational design and validation of a Tip60 histone acetyltransferase inhibitor C Gao, E Bourke, M Scobie, MA Famme, T Koolmeister, T Helleday, ... Scientific reports 4, 5372, 2014 | 124 | 2014 |
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer P McAnena, JAL Brown, K Michael J. Cancers 9 (1), 5, 2017 | 99 | 2017 |
Multiple Facets of the DNA Damage Response Contribute to the Radioresistance of Mouse Mesenchymal Stromal Cell Lines T Sugrue, JAL Brown, NF Lowndes, R Ceredig STEM CELLS 31 (1), 137-145, 2013 | 82 | 2013 |
Circulating microRNAs miR-331 and miR-195 differentiate local luminal A from metastatic breast cancer P McAnena, K Tanriverdi, C Curran, K Gilligan, JE Freedman, JAL Brown, ... BMC Cancer 19, 2019 | 75 | 2019 |
A novel role for hSMG-1 in stress granule formation JAL Brown, TL Roberts, R Richards, R Woods, G Birrell, YC Lim, S Ohno, ... Molecular and cellular biology 31 (22), 4417-4429, 2011 | 64 | 2011 |
Smg1 haploinsufficiency predisposes to tumor formation and inflammation TL Roberts, U Ho, J Luff, CS Lee, SH Apte, KPA MacDonald, LJ Raggat, ... Proceedings of the National Academy of Sciences 110 (4), E285-E294, 2013 | 63 | 2013 |
Targeting cancer using KAT inhibitors to mimic lethal knockouts JAL Brown, E Bourke, LA Eriksson, MJ Kerin Biochemical Society Transactions 44 (4), 979-986, 2016 | 59 | 2016 |
DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2 E Bourke, JAL Brown, S Takeda, H Hochegger, CG Morrison Oncogene 29 (4), 616-624, 2009 | 56 | 2009 |
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options PF McAnena, A McGuire, A Ramli, C Curran, C Malone, R McLaughlin, ... BMC cancer 18 (1), 203, 2018 | 54 | 2018 |
Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer MC Casey, KJ Sweeney, JAL Brown, MJ Kerin International journal of cancer 139 (1), 12-22, 2016 | 52 | 2016 |
MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification JAL Brown, E Bourke, C Liptrot, P Dockery, CG Morrison Oncogene 29 (40), 5537-5544, 2010 | 44 | 2010 |
Screening of exosomal microRNAs from colorectal cancer cells C Clancy, S Khan, CL Glynn, E Holian, P Dockery, P Lalor, JAL Brown, ... Cancer Biomarkers 17 (4), 427-435, 2016 | 40 | 2016 |
Large expert-curated database for benchmarking document similarity in biomedical literature search P Brown, R Consortium, Y Zhou DATABASE 2019 (baz085), 1-67, 2019 | 33 | 2019 |
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer MC Casey, A Prakash, E Holian, A McGuire, O Kalinina, A Shalaby, ... BMC Cancer 19 (1), 712, 2019 | 32 | 2019 |
Prospective assessment of microRNA as markers of response to neoadjuvant chemotherapy in breast cancer. A McGuire, MC Casey, R Waldron, H Heneghan, O Kaliningrad, E Holian, ... Cancers 12 (7 10.3390/cancers12071820), 1820, 2020 | 31 | 2020 |
Advances in Precision Medicine: Tailoring Individualized Therapies. KB Matchett, N Lynam-Lennon, RW Watson, JAL Brown Cancers (Basel). 9 (11), E146, 2017 | 29 | 2017 |
Evaluating the effectiveness of a practical inquiry-based learning bioinformatics module on undergraduate student engagement and applied skills JAL Brown Biochemistry and Molecular Biology Education 44 (3), 304–313, 2016 | 28 | 2016 |
Quantifying Tip60 protein level stratifies breast cancer. A McGuire, MC Casey, A Shalaby, E Holian, O Kalinina, C Curran, ... Scientific Reports. 9 (1), 3819, 2019 | 25* | 2019 |